Share on LinkedInShare on LinkedIn

ARTICLE · 25 OCTOBER 2021

Market Intelligence Thought Leadership Award Winner

COVID-19 Key EU Developments, Policy & Regulatory Update No. 63

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

This regular update (no. 63 | 11 October 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Cybersecurity, Privacy & Data Protection).

European UnionCoronavirus (COVID-19)

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • European Commission consults on proposed amendments to General Block Exemption Regulation
  • European Commission approves new and amended Member State measures to support the economy

Trade / Export Controls

  • United States-European Commission Joint Statement: Launch of the Joint COVID-19 Manufacturing and Supply Chain Taskforce

Medicines and Medical Devices

  • EMA recommendations on extra COVID-19 vaccine doses and boosters

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from